Breaking News

Kemwell Facility Completes FDA Inspection

Bangalore oral solids manufacturing facility complied with all FDA requirements

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Kemwell Biopharma, a global bio/pharmaceutical contract development and manufacturing company, announced that its oral solids manufacturing facility located in Bangalore, India has successfully completed its second U.S. Food and Drug Administration (USFDA) inspection. This audit took place for an ANDA filed for a customer. On completion of the inspection, the USFDA inspector concluded that the facility, systems and practices comply with USFDA requirements and no observations were reported on ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters